Sort by
Refine Your Search
-
limitations and develop ideas with a view to the future. Diversity is an integral part of our culture as we promote potential and are committed to upholding genuine equity in education. The Universityof
-
“Research for a life without cancer" is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention
-
social challenges of Advanced Air Mobility (AAM), considering ecological, economic, technological, and sociological factors. The RTG's structured PhD program aims to train young researchers in highly
-
, regionally anchored top university as it focuses on the grand challenges of the 21st century. It develops innovative solutions for the world's most pressing issues. In research and academic programs
-
development. It is one of the world's leading research institutions in its field and offers natural and social scientists from around the world an inspiring environment for excellent interdisciplinary
-
) investigates the pathobiology of human-pathogenic fungi and identifies targets for the development of novel natural product-based antibiotics. The research group Microbiome Dynamics (https://www.leibniz-hki.de
-
“planar scanning probe microscopy”, a flexible approach to scanning probe microscopy developed in our group (Ernst … Reinhard, ACS Photonics 6, 2 (2019)) to turn nanogap cavities into a scanning probe
-
. Dr. med. Alexander Busch investigates the regulation of the hypothalamic-pituitary-gonadal (HPG) axis—a key system in human reproductive development and fertility. The group combines clinical cohorts
-
-pathogenic fungi and identifies targets for the development of novel natural product-based antibiotics. The research group Microbiome Dynamics (https://www.leibniz-hki.de/de/microbiome-dynamics.html ) invites
-
! RESPONSIBILITIES: You will elucidate the molecular mechanisms driving the development of distinct malignant lymphoma subtypes and contribute to the identification of predictive biomarkers and novel therapeutic